PROTAC ER Degrader-10

• UNSPSC Description:

  PROTAC ER Degrader-10 is a potent PROTAC ER degrader and can be used for cancer research. PROTAC ER Degrader-10 is extracted from patent WO2021133886, example 36.

• Target Antigen:

  Estrogen Receptor/ERR; PROTACs

• Type:

  Reference compound

• Related Pathways:

  PROTAC;Vitamin D Related/Nuclear Receptor

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/protac-er-degrader-10.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC1=CC=C([C@@](C2=CC=C(N3CCC(CC3)CN4CCN(C5=CC=C(C(N(C6C(NC(CC6)=O)=O)C7=O)=O)C7=C5)CC4)C=C2)([H])[C@@](C8=CC=CC=C8)([H])CO9)C9=C1

• Molecular Weight:

  739.86

• References & Citations:

  [1]Jie Fan, et al. Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer. Patent WO2021133886.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2504911-58-2